Table 3

Association between residual symptoms domains, pain and functioning
Odds Ratio 95% Wald Confidence Limits
Age 0.990 0.975 1.005
Gender (male vs. female) 1.356 0.886 2.076
Academic degree (high vs. other) 1.580 0.949 2.629
Baseline functioning level (SOFAS) 1.049 1.031 1.067
Episode length (4–24 weeks vs. ≥ 24 weeks) 2.008 1.127 3.579
Episode lenght (≤4 weeks vs. ≥24 weeks) 2.138 1.145 3.992
Absence of residual core mood symptoms 8.728 4.553 16.730
Absence of residual insomnia symptoms 1.796 1.175 2.744
Absence of residual anxiety symptoms and absence of pain 5.257 2.445 11.300
Absence of residual anxiety symptoms and presence of pain 0.412 0.073 2.341
Absence of pain and absence of residual anxiety symptoms 21.669 3.544 132.498
Absence of pain and presence of residual anxiety symptoms 1.700 1.025 2.819

Logistic regression model.

SOFAS = Social and Occupational Functioning Assessment Scale;

Dependent variable: normal level of functioning (SOFAS total score ≥80) after 3 months of antidepressant treatment.

Romera et al.

Romera et al. BMC Psychiatry 2013 13:51   doi:10.1186/1471-244X-13-51

Open Data